Zobrazeno 1 - 10
of 13
pro vyhledávání: '"D B, Kohn"'
Autor:
G Guanechea, C Damián, AJ Thrasher, G Santilli, M Aldea, B Campo, C Mesa Núñez, E Almarza, D León Rico, Uam . Madrid, Spain., M.L. Lozano, JA Bueren, D B Kohn, C. Carrascoso Rubio
Publikováno v:
IBJ Plus.
Autor:
G M, Crooks, D B, Kohn
Publikováno v:
Blood. 82:3290-3297
Gene transfer into human cells using murine amphotropic retroviral vectors is the basic technique used in most current gene therapy studies. The identity of the cell surface receptor for the amphotropic envelope remains unknown and thus its importanc
Autor:
D B, Kohn
Publikováno v:
Current opinion in molecular therapeutics. 1(4)
While gene therapy using hematopoietic stem cells was the first area of investigation in the field, success has proven elusive. However, significant progress has been achieved recently in methods for more effective gene transfer and expression. In ad
Publikováno v:
Current opinion in molecular therapeutics. 2(4)
Publikováno v:
The journal of gene medicine. 2(3)
It has been shown previously that mutations in the cytoplasmic protein kinase, Bruton's tyrosine kinase (BTK) lead to X-linked agammaglobulinemia, an inherited primary immunodeficiency, thus making it a potential candidate for gene therapy.Producer c
Autor:
K I, Weinberg, D B, Kohn
Publikováno v:
Seminars in hematology. 35(4)
The primary immunodeficiencies are a group of rare genetic diseases in which mutations of genes necessary for host defense result in increased susceptibility to infection. In the past 10 years, the genes responsible for most forms of human immunodefi
Autor:
D B, Kohn
Publikováno v:
Clinical and experimental immunology. 107
Gene transfer into haematopoietic stem cells (HSC) has been investigated for treatment of genetic disorders, conferral of chemotherapy resistance and insertion of genes to inhibit HIV-1 replication. Methods have been available for almost a decade to
Autor:
D B, Kohn
Publikováno v:
Bone marrow transplantation. 18
Gene therapy is a novel approach under investigation for the treatment of genetic diseases, cancer and AIDS. Hematopoietic stem cells would be the target cell for correction of hemoglobinopathies, immune deficiencies and lysosomal storage diseases. R
Publikováno v:
Advances in experimental medicine and biology. 394
Publikováno v:
Current Eye Research. 15:1148-1148